| Name | SARS-CoV-2 3CLpro-IN-16 |
|---|
| Description | SARS-CoV-2 3CLpro-IN-16 (Compound 3a) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 2.124 μM). SARS-CoV-2 3CLpro-IN-16 binds to the active site and forms a covalent bond with Cys145 of 3CLpro[1]. |
|---|---|
| Related Catalog | |
| Target |
2.124 μM (SARS-CoV-2 3CLpro)[1] |
| References |
| Molecular Formula | C17H14N2OS |
|---|---|
| Molecular Weight | 294.37 |